Unichem plans to sell drug unit to Mylan for $30 million
MUMBAI (Reuters) - Unichem Laboratories said on Friday it plans to sell a drug manufacturing plant located in central India to a unit of U.S.-based Mylan for 1.6 billion rupees.
The deal is subject to the execution of a definitive agreement between the two drugmakers and regulatory approvals, Unichem said in a statement.
Shares in Unichem Laboratories rose 1.04 percent on Friday to 175.55 rupees when the wider Mumbai market fell 0.16 percent.
(Reporting by Kaustubh Kulkarni; Editing by Prateek Chatterjee)